TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Avansor Pharma Oy
Closing information (x1000 NOK)
Closing information | 2016/12 | 2015/12 | 2014/12 |
Turnover |
18,000
|
12,255
|
14,333 |
Financial expenses |
82
|
48
|
9 |
Earnings before taxes |
7,078
|
4,024
|
3,375 |
Total assets |
35,446
|
32,243
|
26,132 |
Current assets |
16,246
|
5,554
|
7,438 |
Current liabilities |
5,007
|
3,307
|
2,416 |
Equity capital |
27,713
|
26,077
|
23,716 |
- share capital |
291
|
306
|
290 |
Employees (average) | 3 |
Financial ratios
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Solvency |
78.2%
|
80.9%
|
90.8% |
Turnover per employee | 4,778 | ||
Profit as a percentage of turnover |
39.3%
|
32.8%
|
23.5% |
Return on assets (ROA) |
20.2%
|
12.6%
|
12.9% |
Current ratio |
324.5%
|
167.9%
|
307.9% |
Return on equity (ROE) |
25.5%
|
15.4%
|
14.2% |
Change turnover |
6,351
|
-2,887 | |
Change turnover % |
55%
|
-19% | |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.